Welcome to our dedicated page for Nike Cl B SEC filings (Ticker: NKE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The NIKE, Inc. (NYSE: NKE) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Nike is incorporated in Oregon and listed under Commission File Number 1-10635, and it files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, among other documents.
Through its filings, Nike reports detailed information about its financial condition, results of operations, governance and compensation programs. Current reports on Form 8-K are used to furnish quarterly earnings press releases under Item 2.02, describe leadership and organizational changes under Item 5.02, report shareholder meeting results and stock incentive plan approvals, and disclose other events such as corrections to previously reported product purchase obligations. These filings complement the company’s earnings releases by providing formal regulatory context and, in some cases, incorporating exhibits like press releases and plan documents.
On this page, users can review Nike’s 8-K filings that announce quarterly results for periods such as the quarters ended May 31, August 31 and November 30, as well as filings that describe changes to senior leadership roles, amendments to the NIKE, Inc. Stock Incentive Plan, and outcomes of the annual meeting of shareholders. Filings may also address matters like director retirements, director nominations and clarifications of previously disclosed information.
Stock Titan enhances these filings with AI-powered summaries that explain the key points of lengthy documents, helping readers quickly understand topics such as revenue trends, regional performance, changes in executive roles and updates to equity compensation plans. Real-time updates from the SEC’s EDGAR system ensure that new Nike filings, including Forms 10-K, 10-Q and 8-K, appear promptly. Users can also track governance-related disclosures and other material events that Nike reports for compliance with U.S. securities laws.
Thasunda Duckett, a director of NIKE, Inc. (NKE), received a grant of restricted Class B common stock on 09/09/2025. The grant was for 2,619 shares issued under the NIKE, Inc. Stock Incentive Plan at a $0 price, increasing her beneficial ownership to 13,589 Class B shares. The restricted shares vest in full on the earlier of the next annual shareholders meeting or the last day of the 12th full calendar month after the grant.
Monica Gil, a director of NIKE, Inc. (NKE), reported receipt of 2,619 restricted shares of Class B common stock on 09/09/2025 under the NIKE, Inc. Stock Incentive Plan at a reported price of $0. After the grant, Ms. Gil beneficially owns 8,893 shares. The restricted shares vest in full on the earlier of the next annual shareholder meeting or the last day of the 12th full calendar month after the grant date. The Form 4 was signed on behalf of Ms. Gil by an attorney-in-fact on 09/11/2025.
NIKE, Inc. director Maria Henry received 2,619 restricted Class B common shares on 09/09/2025 under the NIKE, Inc. Stock Incentive Plan. The filing shows 2,619 shares granted at $0, bringing Ms. Henry's beneficial ownership to 8,767 shares after the transaction. The restricted shares vest in full on the earlier of the next annual shareholders' meeting or the last day of the 12th full calendar month after the grant. The Form 4 was signed on behalf of Ms. Henry by an attorney-in-fact on 09/11/2025.
NIKE, Inc. (NKE) director Henry Peter B. received 2,619 restricted Class B common shares on 09/09/2025 under the company's Stock Incentive Plan, at no cash price, increasing his beneficial ownership to 11,099 shares. The restricted shares vest in full on the earlier of the next annual shareholders' meeting or the last day of the 12th full calendar month after grant, per the filing. The Form 4 was signed by an attorney-in-fact on 09/11/2025. The filing reports a routine director equity award designed as short-term restricted stock rather than an option or sale.
Michelle A. Peluso, a Nike, Inc. director, received 2,619 restricted shares of Class B Common Stock on 09/09/2025 under the NIKE, Inc. Stock Incentive Plan. The grant was reported on a Form 4 filed jointly by one reporting person and executed by an attorney-in-fact on 09/11/2025. The transaction shows an acquisition (A) of 2,619 shares at a reported price of $0, increasing Ms. Peluso's beneficial ownership to 32,814 shares. The awarded restricted shares vest in full on the earlier of the next annual meeting of shareholders or the last day of the 12th full calendar month after the grant date.
John W. Rogers Jr., a director of NIKE, Inc. (NKE), was granted 2,619 restricted Class B common shares on 09/09/2025 under the NIKE, Inc. Stock Incentive Plan. The shares were issued at a reported price of $0 and increase his total beneficial ownership to 37,022 Class B shares following the grant. The restricted shares vest in full on the earlier of the next annual shareholders meeting or the last day of the 12th full calendar month after the grant date.
Robert Holmes Swan, a director of NIKE, Inc. (NKE), was granted 2,619 restricted Class B common shares on 09/09/2025 at a reported price of $0 under the NIKE, Inc. Stock Incentive Plan. After the grant he beneficially owns 34,602 shares directly and 1,580 shares indirectly through the Swan Family Revocable Trust. The restricted shares vest in full on the earlier of the next annual shareholders' meeting or the last day of the 12th full calendar month after the grant. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Swan on 09/11/2025.
NIKE, Inc. amended and restated its Stock Incentive Plan and shareholders approved the amended Plan at the virtual annual meeting on September 9, 2025. The approved amendment increases the number of Class B Common Stock shares authorized for issuance under the Plan by 45,000,000 shares. The Company originally adopted the amendment and restatement on July 17, 2025, and described the changes in its definitive proxy statement filed that day. The full text of the amended Plan is attached to the filing as Exhibit 10.1 and is incorporated by reference. The filing also reports that the annual meeting was held virtually and that various proposals, including director elections, were submitted to shareholders for a vote.
Robert Leinwand, Executive Vice President and Chief Legal Officer of NIKE, Inc. (NKE), reported a sale of 1,019 Class B common shares on 09/05/2025 at a price of $74.64 per share pursuant to a 10b5-1 trading plan adopted on 11/14/2024. After the transaction the filing shows 44,855.2318 shares beneficially owned directly and an additional 1,464 shares held indirectly in the company 401(k) plan; some shares reflected include acquisitions under NIKE's Employee Stock Purchase Plan. The sale was executed under company trading-window policy and no derivative transactions were reported.
Nike, Inc. (NKE) Form 144: The filing notifies a proposed sale of 1,019 Class B shares with an aggregate market value of $76,058.16 based on an outstanding share count of 1,188,015,740. The planned sale date is 09/05/2025 on the NYSE. The shares were acquired on 09/01/2025 through restricted stock vesting from the issuer, with payment characterized as compensation. The filer also reported a sale during the past three months by Robert Leinwand of 1,644 Class B shares on 08/05/2025 for $123,152.04. The form includes the standard representation that the selling person is not aware of undisclosed material adverse information and a signature/attestation requirement. Certain filer identification fields appear blank in the provided text.